2 shRNA-transfected cells in S phase was significantly decreased compared with of control. Over-expression of NRF2 significantly increased the percentage of cells in G0/G1 at 48 h compared with that of control. The percentage of NRF2-transfected cells in S phase increased compared with control . These results suggest that Overexpression of NRF2 increased the basal proliferation rates and promotes DNA replication of the Siha cell lines. There were 14.13% 7 / 13 NRF2 in Cervical Cancer Fig 2. The detection of 
NRF2 protein transfection with mimics and inhibitor. Morphology of transfected Siha cells for 48 h under microscopy. A. Transfection with Short interfering RNA; B. transfection with mimics; C. The levels of NRF2 protein detected by Western blotting after transfection for 72 h.1 and 2 were normal control; 3 and 4 were Knockdown group; 5 and 6 were normal control; 7 and 8 were overexpression group; D The relative expression of NRF2 was displayed, which normalized to b-tubulin. There is a statistically significant Neuromedin N difference between the group transfected with NRF2 mimics, NRF2 inhibitor and normal control. doi:10.1371/journal.pone.0133876.g002 0.51% of SiHa cells that demonstrated apoptotic changes 48 h after NRF2 knockdown; this was a significant increase compared with control. By contrast, overexpression of NRF2 did not significantly change apoptosis. NRF2 induces cell migration and invasion in SiHa cells Invasive growth is an important biological characteristic of malignant cancer cells. To investigate the role of NRF2 in cell PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19755095 motility, we performed a Transwell assay in Siha cells. The results show that Cell migration abilities was enhanced after NRF2 over-expression PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19755349 compared with control, and Siha cells with reduced expression of NRF2 were inhibited the migration ability. Overexpression of NRF2 increased the invasive abilities of Siha cells. As expected, Siha cells with reduced expression of NRF2 were less invasive compared with control cells.These results suggest that NRF2 promotes migration and invasion in SiHa cells. Discussion The Keap1 and NRF2 pathway is a critical regulator of cellular responses to oxidative and electrophilic stressors. Keap1/NRF2 protects normal cells from carcinogenesis but also promotes survival of transformed cells in unfavorable conditions. This is the first report of increased Keap1/NRF2 signaling as a result of KEAP1 hypermethylation in cervical cancer. In addition, this is the first report to show an association between NRF2/Keap1 staining and clinicopathological features in cervical cancer. Keap1 binds to and sequesters NRF2 in the cytoplasm, preventing rapid degradation of NRF2. NRF2 translocates to the nucleus, inducing transcription of downstream cytoprotective genes. However, Keap1 has also been shown to be dysfunctional in non-small cell lung carcinomas that have elevated levels of NRF2.Thus, the NRF2/ Keap1 system may be dysregulated in human cervical cancers. Further, nuclear translocation of NRF2 may occur through a Keap1-independent pathway in cervical cancers. Constitutive NRF2 activation due to Keap1 dysfunction and hypermethylation has been reported. The frequency of KEAP1 promoter hypermethylation varies among tumor types. The highest frequency of promoter hypermethylation was found in malignant gliomas , non-small cell lung cancer, colorectal carcinoma, and breast cancer. In breast cancer, methylation was more frequent in ER-positive/HER2-negative tumors as compared with triple-negative
